WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke NANO SENSE wurde als Wortmarke am 26.03.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1433376 |
| Länder | 
|
| Basismarke |
Nr. 87625966,
28. September 2017
|
| Anmeldedatum | 26. März 2018 |
| Ablaufdatum | 29. August 2022 |
Markeninhaber
1705 Guadalupe St., FL 4
Austin TX 78701
US
Austin TX 78701
US
Markenvertreter
Rothwell, Figg, Ernst & Manbeck, PC,
607 14th Street NW, Suite 800
US
Waren und Dienstleistungen
09
Electronic device for the detection, measurement, or
identification of in vitro or in vivo pathobiological cells
or substances, which are capable of causing disease to a
lifeform or are some diseased portion of a lifeform (terms
too vague in the opinion of the International Bureau - Rule
13 (2) (b) of the Common Regulations); hardware,
accessories, and software associated with such a device
(terms too vague in the opinion of the International Bureau
- Rule 13 (2) (b) of the Common Regulations); software for
interacting and controlling an in vitro or in vivo
electronic device for the detection, measurement, or
identification of pathobiological cells or substances;
monitoring system or device comprised of meters, sensors, or
cameras to measure in vitro or in vivo environmental
factors, namely, pressure, humidity, temperature, ambient
sound, location, electromagnetism, ambient light, ambient
wireless signals, ambient particulates, radiation, airflow,
motion, capacitance, tilt, acceleration, force, smoke,
ambient electromagnetic sources, RFID, or angular momentum
(terms too vague in the opinion of the International Bureau
- Rule 13 (2) (b) of the Common Regulations); monitoring
system or device comprised of meters, sensors, or cameras to
help identify, measure, or detect in vitro or in vivo
pathobiological cells or substances (terms too vague in the
opinion of the International Bureau - Rule 13 (2) (b) of the
Common Regulations); hardware, accessories, and software
associated with such a device; software for interacting and
controlling an in vitro or in vivo electronic device for the
detection, measurement, or identification of pathobiological
cells or substances
10
An in vitro or in vivo electronic device for the detection,
measurement, or identification of pathobiological cells or
substances, which are capable of causing disease to a
lifeform or are some diseased portion of a lifeform (terms
too vague in the opinion of the International Bureau - Rule
13 (2) (b) of the Common Regulations); monitoring system or
device comprised of meters, sensors, or cameras to measure
in vitro or in vivo environmental factors, namely, pressure,
humidity, temperature, ambient sound, location,
electromagnetism, ambient light, ambient wireless signals,
ambient particulates, radiation, airflow, motion,
capacitance, tilt, acceleration, force, smoke, ambient
electromagnetic sources, RFID, or angular momentum (terms
too vague in the opinion of the International Bureau - Rule
13 (2) (b) of the Common Regulations); monitoring system or
device comprised of meters, sensors, or cameras to help
identify, measure, or detect in vitro or in vivo
pathobiological cells or substances (terms too vague in the
opinion of the International Bureau - Rule 13 (2) (b) of the
Common Regulations)
42
Monitoring services, namely, the monitoring of in vitro or
in vivo environmental factors, namely, pressure, humidity,
temperature, ambient sound, location, electromagnetism,
ambient light, ambient wireless signals, ambient
particulates, radiation, airflow, motion, capacitance, tilt,
acceleration, force, smoke, ambient electromagnetic sources,
RFID, or angular momentum using environmental sensors and
detector (terms too vague in the opinion of the
International Bureau - Rule 13 (2) (b) of the Common
Regulations); monitoring services, namely, the monitoring of
in vitro or in vivo pathobiological cells or substances,
which are capable of causing disease to a lifeform or are
some diseased portion of a lifeform (terms too vague in the
opinion of the International Bureau - Rule 13 (2) (b) of the
Common Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 11. Juli 2023 | 2023/28 Gaz | US | RAW: Total Ceasing Effect |
| 22. September 2022 | 2022/40 Gaz | SY | Ablehnung |
| 05. April 2022 | 2022/39 Gaz | CU | RAW: Second Part Fee Not Paid |
| 05. April 2022 | 2022/15 Gaz | CU | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 09. Februar 2022 | 2022/10 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. August 2021 | 2021/36 Gaz | TR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. September 2020 | 2020/37 Gaz | IS | Ablehnung |
| 11. Juni 2020 | 2020/25 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. Mai 2020 | 2020/19 Gaz | UA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. April 2020 | 2020/17 Gaz | NO | Ablehnung |
| 30. März 2020 | 2020/21 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 19. März 2020 | 2020/17 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 07. März 2020 | 2020/11 Gaz | NZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 02. Januar 2020 | 2020/1 Gaz | KR | Ablehnung |
| 23. Dezember 2019 | 2020/1 Gaz | IS | Ablehnung |
| 04. Dezember 2019 | 2019/51 Gaz | IL | Ablehnung |
| 28. November 2019 | 2019/48 Gaz | JP | Ablehnung |
| 07. November 2019 | 2019/45 Gaz | LI | Ablehnung |
| 05. November 2019 | 2019/45 Gaz | VN | Ablehnung |
| 24. Oktober 2019 | 2019/45 Gaz | CH | Ablehnung |
| 22. Oktober 2019 | 2019/44 Gaz | IR | Ablehnung |
| 14. Oktober 2019 | 2019/44 Gaz | CU | Ablehnung |
| 08. Oktober 2019 | 2019/41 Gaz | OA | Ablehnung |
| 11. September 2019 | 2020/11 Gaz | MX | Ablehnung |
| 09. September 2019 | 2019/37 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 30. Juli 2019 | 2019/31 Gaz | KR | Ablehnung |
| 29. Juli 2019 | 2019/31 Gaz | UA | Ablehnung |
| 26. Juli 2019 | 2019/46 Gaz | MA | Ablehnung |
| 18. Juli 2019 | 2019/30 Gaz | CO | Ablehnung |
| 16. Juli 2019 | 2019/29 Gaz | NO | Ablehnung |
| 26. Juni 2019 | 2019/26 Gaz | RO | Ablehnung |
| 12. Juni 2019 | 2019/25 Gaz | AU | Ablehnung |
| 30. Mai 2019 | 2019/23 Gaz | CO | Ablehnung |
| 29. Mai 2019 | 2019/23 Gaz | RS | Ablehnung |
| 22. Mai 2019 | 2019/23 Gaz | RU | Ablehnung |
| 20. Mai 2019 | 2019/23 Gaz | IL | Ablehnung |
| 15. April 2019 | 2019/16 Gaz | EM | Ablehnung |
| 03. April 2019 | 2019/14 Gaz | CW | Ablehnung |
| 29. März 2019 | 2019/15 Gaz | NZ | Ablehnung |
| 28. März 2019 | 2019/13 Gaz | PH | Ablehnung |
| 28. März 2019 | 2019/14 Gaz | TR | Ablehnung |
| 03. März 2019 | 2019/11 Gaz | SY | Ablehnung |
| 27. Februar 2019 | 2019/10 Gaz | CN | Ablehnung |
| 02. Februar 2019 | 2019/6 Gaz | SG | Ablehnung |
| 16. Januar 2019 | 2019/3 Gaz | MC | Ablehnung |
| 20. November 2018 | 2018/48 Gaz | IN | Ablehnung |
| 26. März 2018 | 2018/43 Gaz | US | Eintragung |
ID: 141433376